| Literature DB >> 32745617 |
Xiwen Su1, Daniel J McDonough1, Haitao Chu2, Minghui Quan3, Zan Gao4.
Abstract
Continued advancement in the field of physical activity and health promotion relies heavily on the synthesis of rigorous scientific evidence. As such, systematic reviews and meta-analyses of randomized controlled trials have led to a better understanding of which intervention strategies are superior (i.e., produce the greatest effects) in physical activity-based health behavior change interventions. Indeed, standard meta-analytic approaches have allowed researchers in the field to synthesize relevant experimental evidence using pairwise procedures that produce reliable estimates of the homogeneity, magnitude, and potential biases in the observed effects. However, pairwise meta-analytic procedures are only capable to discerning differences in effects between a select intervention strategy and a select comparison or control condition. In order to maximize the impact of physical activity interventions on health-related outcomes, it is necessary to establish evidence concerning the comparative efficacy of all relevant physical activity intervention strategies. The development of network meta-analysis (NMA)-most commonly used in medical-based clinical trials-has allowed for the quantification of indirect comparisons, even in the absence of direct, head-to-head trials. Thus, it stands to reason that NMA can be applied in physical activity and health promotion research to identify the best intervention strategies. Given that this analysis technique is novel and largely unexplored in the field of physical activity and health promotion, care must be taken in its application to ensure reliable estimates and discernment of the effect sizes among interventions. Therefore, the purpose of this review is to comment on the potential application and importance of NMA in the field of physical activity and health promotion, describe how to properly and effectively apply this technique, and suggest important considerations for its appropriate application in this field. In this paper, overviews of the foundations of NMA and commonly used approaches for conducting NMA are provided, followed by assumptions related to NMA, opportunities and challenges in NMA, and a step-by-step example of developing and conducting an NMA.Entities:
Keywords: Behavior change; Kinesiology and health promotion; Multiple treatment comparison; Pairwise meta-analysis; Randomized controlled trials
Mesh:
Year: 2020 PMID: 32745617 PMCID: PMC7749244 DOI: 10.1016/j.jshs.2020.07.011
Source DB: PubMed Journal: J Sport Health Sci ISSN: 2213-2961 Impact factor: 7.179
Fig. 1Example of a network of 3 treatments compared in 2 trials (solid black lines), where an indirect comparison can be made using network meta-analysis (dot blue line).
Fig. 2Comparisons between pairwise meta-analysis versus network meta-analysis in the use of direct and indirect evidence. (A) Represents an example of pairwise meta-analysis and (B) Shows the biggest advantage for network meta-analysis when a common comparator “a” exists. Solid lines represent direct comparisons and dash lines represent indirect comparisons.
Fig. 3The overall concept of the Bayesian approach using a Markov Chain Monte Carlo (MCMC) simulation. P = probability.
Comparison of important features of 3 R packages capable of carrying out an NMA.
| Task | Feature | |||
|---|---|---|---|---|
| Estimation framework | Bayesian | √ | √ | |
| Frequentist | √ | |||
| Forms of input data | Arm-level data | √ | √ | |
| Contrast-level data | √ | √ | ||
| Accepts multi-arm (≥ 3) trials | √ | √ | √ | |
| Types of outcome data that can be analyzed | Binary | √ | √ | √ |
| Count | √ | √ | ||
| Continuous | √ | √ | √ | |
| Survival | √ | √ | ||
| Extracts descriptive measures | Total number of studies | √ | √ | |
| Total number of multi-arm studies | √ | √ | ||
| Total number of participants | √ | |||
| Total number of treatments | √ | √ | ||
| Network plot and options | Network plot | √ | √ | √ |
| Add node labels | √ | √ | √ | |
| Node size reflects network characteristic | √ | |||
| Edge thickness reflects network characteristic | √ | √ | ||
| Assessing heterogeneity | Visual inspection—forest plot | √ | √ | |
| Pairwise statistics | √ | √ | ||
| Global statistics | √ | √ | ||
| Assessing inconsistency | Visual inspection—forest plot of direct | √ | ||
| Visual inspection—heat map | √ | |||
| Consistency statistics | √ | √ | ||
| Back-calculation | √ | |||
| Node-split/decomposition | √ | √ | ||
| MCMC sampler (when under Bayesian modeling) | WinBUGS | N/A | √ | |
| OpenBUGS | N/A | √ | ||
| JAGS | N/A | √ | √ |
Notes: Adapted from Neupane et al. (2014) with premission. Checks indicate the presence of the feature; otherwise the feature does not apply.
Abbreviations: JAGS = Just Another Gibbs Sample; MCMC = Markov Chain Monte Carlo; N/A = not applicable; NMA = network meta-analysis; OpenBUGS = Open Bayesian inference Using Gibbs Sampling; WinBUGS = Windows Bayesian inference Using Gibbs Sampling.
Fig. 4Possible configurations of network plots.
Generic steps in planning and executing an NMA.
| Step | Aim | Consideration |
|---|---|---|
1 | Generate research question | The research question should be constructed with consideration of both the clinical and methodological characteristics of the studies of interest. |
2 | Plan systematic review | This should be guided by the PRISMA extension for an NMA. A clear definition of the T2DM must be presented, and the associated inclusion and exclusion criteria should allow the inclusion of as many relevant interventions and comparators as possible. Potential effect modifiers may be identified. The plan for the systematic review should be registered in PROSPERO and detailed in a study protocol. |
3 | Conduct search | In situations where a large body of literature exists and high-quality systematic reviews have been carried out, the search may focus on identifying these because identifying individual studies through a primary search may not be feasible. |
4 | Select studies | Ideally, 2 independent reviewers should select the studies according to the inclusion and exclusion criteria. Studies that involve interventions that are not central to the research question may be included if they are compared to interventions that are central to the research question and provide more useful evidence to the network. |
5 | Extract data | This stage will generally focus on extracting the relevant data regarding outcomes and potential effect modifiers. Risk of bias and evidence quality should be assessed using the tools provided by Cochrane and GRADE because these characteristics also affect transitivity. |
6 | Build network | Decisions regarding splitting and lumping are made at this stage, and planned approaches may have to be modified according to the nature of the collected data. For example, if there is a lack of data, some lumping may have to be done. A network diagram should be constructed, and its geometry should be evaluated, e.g., |
7 | Analyze data | For all comparisons for which there are both direct and indirect evidence, consistency checks should be carried out to ensure that the direct and indirect evidence agree. Generally, pairwise analyses are conducted first and then NMA models are conducted. The data should be analyzed as set out in the study protocol. |
8 | Interpret and report results | The PRISMA extension for an NMA provides guidance on reporting the results in a clear and comprehensive manner. Data from individual studies should be summarized in tables. The estimates of comparative effectiveness are usually presented in tables and sometimes in a rankogram. |
Note: Adopted from Molloy et al. (2018) with permission.
Abbreviations: GRADE = The Grading of Recommendations Assessment, Development, and Evaluation; NMA = network meta-analysis; PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PROSPERO = Prospective Register of Systematic Reviews; T2DM = type 2 diabetes mellitus.